UTERINE LEIOMYOSARCOMA

This adverse event was reported 80 times

These drugs are most commonly taken by patients reporting UTERINE LEIOMYOSARCOMA:

# Drug Count
0 PAZOPANIB HYDROCHLORIDE 17
1 DOCETAXEL 10
2 DOCETAXEL ANHYDROUS 10
3 GEMCITABINE 8
4 GEMCITABINE HYDROCHLORIDE 8
5 TRABECTEDIN 5
6 AMLODIPINE 3
7 DOXORUBICIN 3
8 INTERFERON BETA-1A 3
9 LEVONORGESTREL 3
See all common drugs associated with UTERINE LEIOMYOSARCOMA

UTERINE LEIOMYOSARCOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRABECTEDIN 5 0.0021
1 LAROTRECTINIB 1 0.0011
2 PAZOPANIB HYDROCHLORIDE 17 0.0006
3 RYDAPT 1 0.0005
4 GLATIRAMER ACETATE INJECTION 1 0.0002
5 TAMOXIFEN CITRATE 1 0.0002
6 GEMCITABINE HYDROCHLORIDE 8 0.0001
7 DOCETAXEL ANHYDROUS 10 0.0001
8 DOCETAXEL 10 0.0001
9 FOSCARBIDOPA/FOSLEVODOPA 1 0.0001
See all drugs enriched for association with UTERINE LEIOMYOSARCOMA